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Abstract
© 2016, Springer Science+Business Media New York.Mesenchymal stem cells (MSCs) can be
used to develop new methods for cancer therapy because they have tropism for tumor niche.
Currently,  in  clinical  practice,  the  multipotent  MSCs  from  adipose  tissue  (hADSCs)  are
considered to be promising cell type for therapy of various human diseases. These cells can
serve as vectors to deliver therapeutic molecules into the tumor microenvironment. A new
direction  in  the  development  of  cancer  cell  therapy  is  to  prime  culture  of  MSCs  with
chemotherapeutic drugs. In such preparations, MSCs can provide targeted delivery of the drug
not only into tumors but also to distant metastasis and premetastatic niches. However, the
effect  of  these  drugs  on  the  MSCs  biological  properties  is  poorly  understood.  In  cancer
chemotherapy, cisplatin is one of effective cytotoxic drugs, which is used to treat various types
of tumors. In the present study, we investigated the effects of the cisplatin chemotherapeutic
drug on hADSCs and showed that concentration of 2.5 and 5 μg/ml of cisplatin has no effect on
the viability, morphology, and ultrastructure of cells.
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